What do we do?
Our work allows cancer drugs to be efficiently produced, and delivered to cancerous tumors in a targeted fashion that doesn’t destroy the patient’s normal healthy cells indiscriminantly. We do this by simplifying and standardizing the production of antibody drug conjugates to treat cancer, using proprietary site-selective chemistries as protein modification technologies.
Who are we?
We are established scientists and medical professionals determined to treat people around world with superior, targeted cancer therapeutics.
Partnership opportunities
Leverage our novel chemistries to create your superior targeted therapeutics to treat cancer.
Investment opportunities
We have two parallel development paths: platform technology with the ability to be licensed by others and our own proprietary therapeutic products to treat cancer
Latest News and Events
ADVANCED PROTEOME THERAPEUTICS ANNOUNCES APPOINTMENT OF BILL DICKIE AS CHIEF EXECUTIVE OFFICER AND DIRECTOR
VANCOUVER, British Columbia, June 06, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8) is pleased to announce the appointment of Mr. Bill Dickie as Chief Executive Officer, President and Director of the company, effective June 6, 2018. Mr. Dickie brings with him more than 30 years [...]